These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16053912)

  • 1. Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
    Bernard PH; Ged C; Faivre E; Legac G; Bioulac-Sage P; Cassaigne A; de Verneuil H
    Eur J Med Genet; 2005; 48(2):195-8. PubMed ID: 16053912
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India.
    Dhillon BK; Das R; Garewal G; Chawla Y; Dhiman RK; Das A; Duseja A; Chandak GR
    World J Gastroenterol; 2007 Jun; 13(21):2956-9. PubMed ID: 17589946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of a liver with the C282Y mutation into a recipient heterozygous for H63D results in iron overload.
    Ismail MK; Martinez-Hernandez A; Schichman S; Chaudhry S; Waters B
    Am J Med Sci; 2009 Feb; 337(2):138-42. PubMed ID: 19214033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
    Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
    Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients.
    Altes A; Ruiz A; Martinez C; Esteve A; Vela MD; Remacha AF; Sarda P; Bach V; Baiget M
    Ann Hematol; 2007 Nov; 86(11):831-5. PubMed ID: 17639389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical consequences of iron overload in hemochromatosis homozygotes.
    Ajioka RS; Kushner JP
    Blood; 2003 May; 101(9):3351-3; discussion 3354-8. PubMed ID: 12707221
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P; Lonardo A; Carulli N
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron in the era of molecular biology].
    Deugnier Y; Moirand R; Brissot P; David V
    Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding.
    Fleming RE; Sly WS
    J Clin Invest; 2001 Aug; 108(4):521-2. PubMed ID: 11518724
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in understanding haemochromatosis: a transition state.
    Robson KJ; Merryweather-Clarke AT; Cadet E; Viprakasit V; Zaahl MG; Pointon JJ; Weatherall DJ; Rochette J
    J Med Genet; 2004 Oct; 41(10):721-30. PubMed ID: 15466004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical penetrance of hereditary hemochromatosis.
    Bacon BR; Britton RS
    N Engl J Med; 2008 Jan; 358(3):291-2. PubMed ID: 18199868
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of HFE C282Y homozygotes younger than age 30 years.
    Barton JC; Felitti VJ; Lee P; Beutler E
    Acta Haematol; 2004; 112(4):219-21. PubMed ID: 15564736
    [No Abstract]   [Full Text] [Related]  

  • 18. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
    Phatak PD; Barton JC
    Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of iron overload syndrome].
    Polunina TE; Maev IV
    Eksp Klin Gastroenterol; 2010; (5):61-8. PubMed ID: 20731136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S; Marconi S; Sikorska K; Naeem R; Nash G
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.